← FDA Drug Approvals (Drugs@FDA)

BILIVIST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAYER HLTHCARE · Approved 1982-08-11

Drug application

FDA Application #

ANDA087768

Application type

Abbreviated New Drug Application (Generic)

Brand name

BILIVIST

Generic name

Ipodate Sodium

Active ingredients

IPODATE SODIUM

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

BAYER HLTHCARE

First approval

1982-08-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown